Intelligent Bio Solutions (INBS), INBS, announced that Managed Waste Service, MWS, a leading Australian waste management provider, plans to implement INBS’ Intelligent Fingerprinting Drug Screening System across its New South Wales operations, including its land clearing and green waste processing sites. The decision marks MWS’s first move into in-house drug testing across multiple locations, with more than 20 sites simultaneously engaged in remote testing operations. MWS plans to conduct pre-employment, random, and for-cause testing on-site, giving operational teams complete control over safety processes without the disruption associated with traditional outsourced models.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on INBS:
- Intelligent Bio Solutions expands U.S. forensic market presence
- Intelligent Bio Solutions (NASDAQ: INBS) Showcases Portable Drug Testing System at RISE25
- Intelligent Bio Solutions (NASDAQ: INBS) Progressing with FDA Clearance for Fingerprint Drug Testing as Global Demand Grows
- Intelligent Bio Solutions (NASDAQ: INBS) to Showcase Fingerprint Drug Testing at RISE25 Conference
- Intelligent Bio Solutions to showcase fingerprint drug testing at RISE25